Toyomasa Katagiri
Direktor/Vorstandsmitglied bei Cancer Precision Medicine KK
Aktive Positionen von Toyomasa Katagiri
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The University of Tokushima | Corporate Officer/Principal | 01.05.2008 | - |
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Direktor/Vorstandsmitglied | 01.12.2014 | - |
| Cancer Precision Medicine KK | Direktor/Vorstandsmitglied | 01.05.2018 | - |
Karriereverlauf von Toyomasa Katagiri
Ehemalige bekannte Positionen von Toyomasa Katagiri
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Direktor/Vorstandsmitglied | 01.06.2010 | 31.03.2023 |
Statistik
International
| Japan | 5 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
| Cancer Precision Medicine KK |
- Börse
- Insiders
- Toyomasa Katagiri
- Erfahrung
